Xintela AB (Sweden) Analysis
| XINT Stock | SEK 0.39 0.01 2.63% |
Xintela AB is overvalued with Real Value of 0.34 and Hype Value of 0.39. The main objective of Xintela AB stock analysis is to determine its intrinsic value, which is an estimate of what Xintela AB is worth, separate from its market price. There are two main types of Xintela AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Xintela AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Xintela AB's stock to identify patterns and trends that may indicate its future price movements.
The Xintela AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Xintela AB is usually not traded on Good Friday, Epiphany, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day. Xintela Stock trading window is adjusted to Europe/Stockholm timezone.
Xintela |
Xintela Stock Analysis Notes
About 59.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.73. Xintela AB had not issued any dividends in recent years. Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 13 people. For more information please call the company at 46 4 62 75 65 00 or visit https://www.xintela.se.Xintela AB Investment Alerts
| Xintela AB had very high historical volatility over the last 90 days | |
| Xintela AB has some characteristics of a very speculative penny stock | |
| Xintela AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (58.39 M) with profit before overhead, payroll, taxes, and interest of 2.08 M. | |
| Xintela AB has accumulated about 11.14 M in cash with (42.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 59.0% of the company outstanding shares are owned by insiders |
Xintela Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 143.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Xintela AB's market, we take the total number of its shares issued and multiply it by Xintela AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 20th of July, Xintela AB maintains the Mean Deviation of 4.22, downside deviation of 5.45, and Market Risk Adjusted Performance of 1.12. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xintela AB, as well as the relationship between them.Xintela AB Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of Xintela AB for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Xintela AB short-term fluctuations and highlight longer-term trends or cycles.
Xintela AB Outstanding Bonds
Xintela AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Xintela AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Xintela bonds can be classified according to their maturity, which is the date when Xintela AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Xintela AB Predictive Daily Indicators
Xintela AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Xintela AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Xintela AB Forecast Models
Xintela AB's time-series forecasting models are one of many Xintela AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xintela AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Xintela Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Xintela AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xintela shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xintela AB. By using and applying Xintela Stock analysis, traders can create a robust methodology for identifying Xintela entry and exit points for their positions.
Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 13 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Xintela AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.